| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
0 | 0 | 0 | 0 | 0 |
| Selling, General and Administrative Expenses
|
-23 | -23 | -39 | -38 | -41 |
|
Operating Income/Expenses
|
-23 | -23 | -39 | -38 | -41 |
|
Total Operating Profit/Loss
|
-23 | -23 | -39 | -38 | -41 |
| Total Net Finance Income/Expense
|
109 | 109 | 117 | 100 | 56 |
|
Non-Operating Income/Expenses, Total
|
109 | 109 | 117 | 100 | 56 |
|
Pretax Income
|
86 | 86 | 78 | 62 | 15 |
|
Net Income from Continuing Operations
|
86 | 86 | 78 | 62 | 15 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
86 | 86 | 78 | 62 | 15 |
|
Net Income after Non-Controlling/Minority Interests
|
86 | 86 | 78 | 62 | 15 |
|
Net Income Available to Common Stockholders
|
86 | 86 | 78 | 62 | 15 |
|
Diluted Net Income Available to Common Stockholders
|
86 | 86 | 78 | 62 | 15 |
| Basic EPS
|
0.07 | 0.07 | 0.06 | 0.05 | 0.01 |
| Diluted EPS
|
0.07 | 0.07 | 0.06 | 0.05 | 0.01 |
|
Basic Weighted Average Shares Outstanding
|
1,255.6400 | 1,255.6400 | 1,255.6400 | 1,255.6400 | 1,255.6400 |
|
Diluted Weighted Average Shares Outstanding
|
1,255.6400 | 1,255.6400 | 1,255.6400 | 1,255.6400 | 1,255.6400 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-23 | -23 | -39 | -38 | -41 |
|
EBITDA
|
-23 | -23 | -39 | -38 | -41 |
|
Normalized EBITDA
|
-23 | -23 | -39 | -38 | -41 |
|
Normalized Income
|
86 | 86 | 78 | 62 | 15 |
|
Total Unusual Items
|
0 | 0 | 0 | 0 | 0 |
|
Total Unusual Items Excluding Goodwill
|
0 | 0 | 0 | 0 | 0 |
|
Tax Effect of Unusual Items
|
0 | 0 | 0 | 0 | 0 |
|
Tax Rate, Calculated
|
0.23 | 0.23 | 0.23 | 0.23 | 0.23 |
12/31/2022 - 12/2/1999
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade
